Vericel Corp. (VCEL)
40.15
+0.71
(+1.80%)
USD |
NASDAQ |
Oct 02, 16:00
40.15
0.00 (0.00%)
After-Hours: 20:00
Vericel Market Cap : 2.055B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.055B |
| October 01, 2026 | 2.018B |
| September 30, 2026 | 2.054B |
| September 29, 2026 | 2.078B |
| September 28, 2026 | 2.059B |
| September 25, 2026 | 2.032B |
| September 24, 2026 | 2.011B |
| September 23, 2026 | 1.985B |
| September 22, 2026 | 2.058B |
| September 21, 2026 | 2.024B |
| September 18, 2026 | 2.048B |
| September 17, 2026 | 2.048B |
| September 16, 2026 | 2.058B |
| September 15, 2026 | 2.033B |
| September 14, 2026 | 2.026B |
| September 11, 2026 | 1.962B |
| September 10, 2026 | 1.938B |
| September 09, 2026 | 1.995B |
| September 08, 2026 | 2.000B |
| September 04, 2026 | 2.057B |
| September 03, 2026 | 2.071B |
| September 02, 2026 | 2.092B |
| September 01, 2026 | 2.072B |
| August 31, 2026 | 2.042B |
| August 28, 2026 | 2.095B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.107B |
| August 26, 2026 | 2.172B |
| August 25, 2026 | 2.212B |
| August 24, 2026 | 2.165B |
| August 21, 2026 | 2.184B |
| August 20, 2026 | 2.155B |
| August 19, 2026 | 2.230B |
| August 18, 2026 | 2.265B |
| August 17, 2026 | 2.231B |
| August 14, 2026 | 2.262B |
| August 13, 2026 | 2.279B |
| August 12, 2026 | 2.289B |
| August 11, 2026 | 2.269B |
| August 10, 2026 | 2.249B |
| August 07, 2026 | 2.307B |
| August 06, 2026 | 2.290B |
| August 05, 2026 | 2.321B |
| August 04, 2026 | 2.371B |
| August 03, 2026 | 2.356B |
| July 31, 2026 | 2.352B |
| July 30, 2026 | 2.436B |
| July 29, 2026 | 2.386B |
| July 28, 2026 | 2.390B |
| July 27, 2026 | 2.319B |
| July 24, 2026 | 2.298B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 464.42B |
| ADMA Biologics, Inc. | 2.190B |
| Kyntra Bio, Inc. | 25.55M |
| Conexeu Sciences, Inc. | 84.93M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
Market Cap Related Metrics
| PE Ratio | 86.85 |
| PS Ratio | 6.786 |
| PEG Ratio | 0.3204 |
| Price to Book Value | 5.552 |
| Price to Free Cash Flow | 33.71 |
| Price | 40.15 |
| Earnings Yield | 1.15% |
| PEGY Ratio | 0.3204 |
| Operating PE Ratio | 113.98 |
| Normalized PE Ratio | 86.87 |